Benzinga | Mar 16, 2021 04:02PM EDT

Eton Pharmaceuticals Q4 EPS $(0.32) Misses $(0.26) Estimate, Sales $81.00K Miss $1.33M Estimate

Eton Pharmaceuticals (NASDAQ:ETON) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.26) by 23.08 percent. This is a 113.33 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $81.00 thousand which missed the analyst consensus estimate of $1.33 million by 93.91 percent. This is a 82.35 percent decrease over sales of $459.00 thousand the same period last year.